External site

By following this link, you are leaving Medically and entering a website that is not owned or controlled by Roche. Roche does not take any responsibility for access to or use of this website, nor for any content therein.

Leave site
Roche and Genentech at

ECTRIMS 2022

-
Coming soon
01:15 PM
Duration 5mins Amsterdam, Netherlands / Virtual (Hybrid)
Evolving the paradigm of patient care in MS and forging the path ahead
Hauser S, Zipp F, Ontaneda D

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar
02:49 PM
Duration 7mins Room 5
Pregnancy and infant outcomes in women receiving ocrelizumab▼ for the treatment of multiple sclerosis
Oreja-Guevara C, Vukusic S, Pietrasanta C, McElrath T, Hellwig K, Bove R, Craveiro L, Ferreira G, Lin CJ, Pasquarelli N, Zecevic D, Dobson R

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar
10:40 AM
Duration 7mins Room 6
Increased peripheral inflammatory responses in MOGAD and AQP4+ NMOSD
A Bauer, D Rudzki, K Berek, A Dinoto, C Lechner, EM Wendel, H Hegen, F Deisenhammer, T Berger, R Höftberger, K Rostasy, S Mariotto, M Reindl

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar
10:49 AM
Duration 7mins Room 2
Assessment of upper extremity function and performance fatigability in multiple sclerosis using sensor-based features derived from the smartphone-based Pinching Test
Graves J, Elantkowski M, Zhang Schärer Y-P, Dondelinger F, Lipsmeier F, Bernasconi C, Montalban X, Midaglia L, Lindemann M

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar
04:17 PM
Duration 7mins Amsterdam, The Netherlands
Broader Epstein-Barr virus-specific T-cell receptor repertoire in patients with multiple sclerosis
Tilman Schneider-Hohendorf

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar